Search research articles
Contact Us
Filters
Showing results (321-330 of 342) with videos related to
Page
of 35
Sort By:
Nature Genetics
|
November 14, 2025
Genome-wide association study and polygenic risk prediction of hypothyroidism
Søren A Rand, Gustav Ahlberg, Vinicius Tragante, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 22, 2024
GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly
Mette H Jensen, Lærke S Gasbjerg, Kirsa Skov-Jeppesen, et al.
Plos One
|
November 27, 2024
Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workers
Aleksander Eiken, Sofie Bliddal, Marie Villumsen, et al.
Orphanet Journal of Rare Diseases
|
April 18, 2015
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
Marieke Biegstraaten, Reynir Arngrímsson, Frederic Barbey, et al.
Acta Neuropathologica
|
January 3, 2025
Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors
Jelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Acta Neuropathologica
|
November 23, 2024
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors
Jelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Hemasphere
|
March 11, 2024
Clonal hematopoiesis and COVID-19 hospitalization in Danish adults
Celia Burgos Sequeros, Morten Tulstrup, Sofie Bliddal, et al.
The New England Journal of Medicine
|
August 11, 2016
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
Dominique P Germain, Derralynn A Hughes, Kathleen Nicholls, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 21, 2022
Association of Thyroid Peroxidase Antibodies and Thyroglobulin Antibodies with Thyroid Function in Pregnancy: An Individual Participant Data Meta-Analysis
Sofie Bliddal, Arash Derakhshan, Yi Xiao, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 342) with videos related to
Sort By:
Page
of 35
Nature Genetics
|
November 14, 2025
Genome-wide association study and polygenic risk prediction of hypothyroidism
Søren A Rand, Gustav Ahlberg, Vinicius Tragante, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 22, 2024
GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly
Mette H Jensen, Lærke S Gasbjerg, Kirsa Skov-Jeppesen, et al.
Plos One
|
November 27, 2024
Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workers
Aleksander Eiken, Sofie Bliddal, Marie Villumsen, et al.
Orphanet Journal of Rare Diseases
|
April 18, 2015
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
Marieke Biegstraaten, Reynir Arngrímsson, Frederic Barbey, et al.
Acta Neuropathologica
|
January 3, 2025
Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors
Jelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Acta Neuropathologica
|
November 23, 2024
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors
Jelena Jotanovic, Henning Bünsow Boldt, Mark Burton, et al.
Hemasphere
|
March 11, 2024
Clonal hematopoiesis and COVID-19 hospitalization in Danish adults
Celia Burgos Sequeros, Morten Tulstrup, Sofie Bliddal, et al.
The New England Journal of Medicine
|
August 11, 2016
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
Dominique P Germain, Derralynn A Hughes, Kathleen Nicholls, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 21, 2022
Association of Thyroid Peroxidase Antibodies and Thyroglobulin Antibodies with Thyroid Function in Pregnancy: An Individual Participant Data Meta-Analysis
Sofie Bliddal, Arash Derakhshan, Yi Xiao, et al.
Page
of 35